Yilmaz, B.; Kemal, Y.; Teker, F.; Kut, E.; Demirag, G.; Yucel, I.
(Experimental Oncology, 2014)
Gastrointestinal stromal tumors (GISTs) are uncommon tumors of the gastrointestinal (GI) tract. Regorafenib is a new multikinase inhibitor and is approved for the treatment of GISTs in patients who develop resistance to ...